Non-Oncogene Addiction of KRAS-Mutant Cancers to IL-1β via Versican and Mononuclear IKKβ is a research paper published in Cancers (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
General Secretariat for Research and Innovation and Hellenic Foundation for Research and Innovation
Grant: 1853
General Secretariat for Research and Innovation and Hellenic Foundation for Research and Innovation
Grant: HL61419
General Secretariat for Research and Innovation and Hellenic Foundation for Research and Innovation
Grant: I01 BX002378
General Secretariat for Research and Innovation and Hellenic Foundation for Research and Innovation
Grant: 260524
KRas mutation interactions with host immunity in malignant pleural effusion.
General Secretariat for Research and Innovation and Hellenic Foundation for Research and Innovation
Grant: 679345
Supplying lung adenocarcinoma cell lines to the cancer research community.
General Secretariat for Research and Innovation and Hellenic Foundation for Research and Innovation
Grant: GRK2338
General Secretariat for Research and Innovation and Hellenic Foundation for Research and Innovation
Grant: ALTERNATIVE
General Secretariat of Research and Innovation (GSRI)
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01HL061419-06
Molecular Regulation of Lung Inflammation by NF-kB
FWCI
0.54
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals